Replies to post #1970 on Halozyme Therapeutics Inc (HALO)

[thesuicidekinginvest]

I'm interested in Roche changeover rate from I.V. Herceptin to SC Herceptin, and same for Baxter to HyQ.

Both Roth Capital and Brean Murray analysts are bullish on a fast changeover to SC Herceptin in EU, if approved

[ghmm]

Unfortunately I think this speaks to the lack of interest in their Insulin program

http://www.sec.gov/Archives/edgar/data/1159036/000119312512049207/0001193125-12-049207-index.htm